Ajanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has filed a rumour verification response with the exchange as required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 30(11). This regulation mandates listed companies to confirm, deny, or clarify any market rumour circulating in mainstream media within 24 hours of being reported. The full content of the company's clarification regarding the specific rumour has not been provided in this headline. Investors should look for the company's detailed clarification in the full filing to understand the nature of the rumour and the company's stand on it.
The immediate impact depends entirely on whether the rumour was confirmed, denied, or clarified. A denial or clarification of negative rumour could be neutral to positive for the stock, while a confirmation of any adverse development could trigger a negative reaction. Retail investors should read the full clarification before making any trading decisions.